Erratum: Differential effects of common variants in SCN2A on general cognitive ability, brain physiology, and messenger RNA expression in schizophrenia cases and control individuals (JAMA Psychiatry (2014) 71:6 (647-656) DOI: 10.1001/jamapsychiatry.2014.157);Differential effects of common variants in SCN2A on general cognitive ability, brain physiology, and messenger RNA expression in schizophrenia cases and control individuals

JAMA Psychiatry

Volumn 71, Issue 6, 2014, Pages 647-656

  Dickinson, Dwight ^a   Straub, Richard E ^b   Trampush, Joey W ^a   Gao, Yuan ^b   Feng, Ningping ^a   Xie, Bin ^b   Shin, Joo Heon ^b   Lim, Hun Ki ^b   Ursini, Gianluca ^b,c   Bigos, Kristin L ^b   Kolachana, Bhaskar ^a   Hashimoto, Ryota ^d,e   Takeda, Masatoshi ^d,e   Baum, Graham L ^a   Rujescu, Dan ^f,g   Callicott, Joseph H ^a   Hyde, Thomas M ^a,b   Berman, Karen F ^a   Kleinman, Joel E ^a,b   Weinberger, Daniel R ^a,b,h  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c UNIVERSITY OF BARI   (Italy)

^d OSAKA UNIVERSITY   (Japan)

^e OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^f LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^g MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^h JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; SODIUM CHANNEL NAV1.2;

ADULT; ARTICLE; BRAIN DISEASE; BRAIN FUNCTION; BRAIN TISSUE; COGNITION; COGNITIVE DEFECT; FEMALE; FOLLOW UP; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; GERMANY; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; NATIONAL HEALTH ORGANIZATION; PREFRONTAL CORTEX; RNA SEQUENCE; SCHIZOPHRENIA; SIBLING; SINGLE NUCLEOTIDE POLYMORPHISM; UNITED STATES; WORKING MEMORY;

ADOLESCENT; ADULT; BRAIN; CASE-CONTROL STUDIES; COGNITION; FEMALE; FUNCTIONAL NEUROIMAGING; GENE EXPRESSION; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NAV1.2 VOLTAGE-GATED SODIUM CHANNEL; POLYMORPHISM, SINGLE NUCLEOTIDE; PREFRONTAL CORTEX; RNA, MESSENGER; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SIBLINGS; YOUNG ADULT;

EID: 84902159877     PISSN: 2168622X     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamapsychiatry.2014.871     Document Type: Erratum

References (77)

1. Weinberger DR. Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry. 1987;44(7): 660-669. (Pubitemid 17099795)
2. Weinberger DR, Levitt P. Neurodevelopmental origins of schizophrenia. In:Weinberger DR, Harrison P, eds. Schizophrenia. Vol 165. 3rd ed. Oxford, England: Wiley-Blackwell; 2011:579-587.
3. Chen X, Lee G, Maher BS, et al GROUP Investigators; International Schizophrenia Consortium. GWA study datamining and independent replication identify cardiomyopathy associated 5 (CMYA5) as a risk gene for schizophrenia. Mol Psychiatry. 2011;16(11):1117-1129.
4. O'Donovan MC, Craddock N, Norton N, et al Molecular Genetics of Schizophrenia Collaboration. Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nat Genet. 2008;40(9):1053-1055.
5. Ripke S, O'Dushlaine C, Chambert K, et al Multicenter Genetic Studies of Schizophrenia Consortium; Psychosis Endophenotypes International Consortium;Wellcome Trust Case Control Consortium 2. Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat Genet. 2013;45(10):1150-1159.
6. Dickinson D, Goldberg TE, Gold JM, Elvevåg B, Weinberger DR. Cognitive factor structure and invariance in people with schizophrenia, their unaffected siblings, and controls. Schizophr Bull. 2011;37(6):1157-1167.
7. Dickinson D, RamseyME, Gold JM. Overlooking the obvious: ameta-analytic comparison of digit symbol coding tasks and other cognitive measures in schizophrenia. Arch Gen Psychiatry. 2007;64(5): 532-542. (Pubitemid 46718286)
8. Heinrichs RW, Zakzanis KK. Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. Neuropsychology. 1998;12(3):426-445. (Pubitemid 28323862)
9. Cannon TD, Bearden CE, Hollister JM, Rosso IM, Sanchez LE, Hadley T. Childhood cognitive functioning in schizophrenia patients and their unaffected siblings: a prospective cohort study. Schizophr Bull. 2000;26(2):379-393. (Pubitemid 30423216)
10. Cannon M, Caspi A, Moffitt TE, et al. Evidence for early-childhood, pan-developmental impairment specific to schizophreniform disorder: results from a longitudinal birth cohort. Arch Gen Psychiatry. 2002;59(5):449-456. (Pubitemid 34477681)
11. Lewandowski KE, Cohen BM, Ongur D. Evolution of neuropsychological dysfunction during the course of schizophrenia and bipolar disorder. Psychol Med. 2011;41(2):225-241.
12. Niendam TA, Bearden CE, Rosso IM, et al. A prospective study of childhood neurocognitive functioning in schizophrenic patients and their siblings.AmJ Psychiatry. 2003;160(11):2060-2062. (Pubitemid 39619649)
13. Reichenberg A, Caspi A, Harrington H, et al. Static and dynamic cognitive deficits in childhood preceding adult schizophrenia: a 30-year study. Am J Psychiatry. 2010;167(2):160-169.
14. Egan MF, Goldberg TE, Gscheidle T, et al. Relative risk for cognitive impairments in siblings of patients with schizophrenia. Biol Psychiatry. 2001; 50(2):98-107. (Pubitemid 32728209)
15. Goldberg TE, Torrey EF, Gold JM, et al. Genetic risk of neuropsychological impairment in schizophrenia: a study of monozygotic twins discordant and concordant for the disorder. Schizophr Res. 1995;17(1):77-84.
16. Snitz BE, Macdonald AWIII, Carter CS. Cognitive deficits in unaffected first-degree relatives of schizophrenia patients: ameta-analytic review of putative endophenotypes. Schizophr Bull. 2006;32(1):179-194. (Pubitemid 43063833)
17. Meyer-Lindenberg A, Weinberger DR. Intermediate phenotypes and genetic mechanisms of psychiatric disorders. Nat Rev Neurosci. 2006;7 (10):818-827. (Pubitemid 44435264)
18. Carroll JB. Human Cognitive Abilities: A Survey of Factor-Analytic Studies. New York, NY: Cambridge University Press; 1993.
19. Deary IJ. Human intelligence differences: a recent history. Trends Cogn Sci. 2001;5(3):127-130. (Pubitemid 32181351)
20. Jensen AR. The g Factor: The Science of Mental Ability.Westport, CT: Praeger; 1998.
21. Dickinson D, Ragland JD, Calkins ME, Gold JM, Gur RC. A comparison of cognitive structure in schizophrenia patients and healthy controls using confirmatory factor analysis. Schizophr Res. 2006; 85(1-3):20-29. (Pubitemid 44173013)
22. Gladsjo JA, McAdams LA, Palmer BW, Moore DJ, Jeste DV, Heaton RK. A six-factor model of cognition in schizophrenia and related psychotic disorders: relationships with clinical symptoms and functional capacity. Schizophr Bull. 2004;30(4): 739-754. (Pubitemid 40469511)
23. JohnsonW, te Nijenhuis J, Bouchard Jr TJ. Still just 1 g: consistent results from five test batteries. Intelligence. 2008;36(1):81-95. doi:10.1016/j.intell.2007.06.001.
24. Deary IJ, JohnsonW, Houlihan LM. Genetic foundations of human intelligence. Hum Genet. 2009;126(1):215-232.
25. Deary IJ, Yang J, Davies G, et al. Genetic contributions to stability and change in intelligence from childhood to old age. Nature. 2012;482 (7384):212-215.
26. Bowie CR, Reichenberg A, Patterson TL, Heaton RK, Harvey PD. Determinants of real-world functional performance in schizophrenia subjects: correlations with cognition, functional capacity, and symptoms. Am J Psychiatry. 2006;163(3):418-425. (Pubitemid 44469383)
27. Deary IJ. Intelligence. Annu Rev Psychol. 2012; 63:453-482.
28. Gottfredson LS. What do we know about intelligence? Am Scholar. 1996;(winter):15-30.
29. Green MF. What are the functional consequences of neurocognitive deficits in schizophrenia? Am J Psychiatry. 1996;153(3):321- 330. (Pubitemid 26074706)
30. Green MF, Kern RS, Heaton RK. Longitudinal studies of cognition and functional outcome in schizophrenia: implications forMATRICS. Schizophr Res. 2004;72(1):41-51. (Pubitemid 39452904)
31. Batty GD, Deary IJ. Early life intelligence and adult health. BMJ. 2004;329(7466):585-586. (Pubitemid 39256542)
32. Batty GD, Deary IJ, Gottfredson LS. Premorbid (early life) IQ and later mortality risk: systematic review. Ann Epidemiol. 2007;17(4):278-288. (Pubitemid 46454379)
33. Duncan J, Owen AM. Common regions of the human frontal lobe recruited by diverse cognitive demands. Trends Neurosci. 2000;23(10):475-483.
34. Duncan J, Seitz RJ, Kolodny J, et al. A neural basis for general intelligence. Science. 2000;289 (5478):457-460. (Pubitemid 30490458)
35. Callicott JH, Bertolino A, Mattay VS, et al. Physiological dysfunction of the dorsolateral prefrontal cortex in schizophrenia revisited. Cereb Cortex. 2000;10(11):1078-1092.
36. Davies G, Tenesa A, Payton A, et al. Genome-wide association studies establish that human intelligence is highly heritable and polygenic. Mol Psychiatry. 2011;16(10):996-1005.
37. Devlin B, DanielsM, Roeder K. The heritability of IQ. Nature. 1997;388(6641):468-471. (Pubitemid 27328923)
38. Plomin R, Spinath FM. Intelligence: genetics, genes, and genomics. J Pers Soc Psychol. 2004;86 (1):112-129. (Pubitemid 38142814)
39. Wisdom NM, Callahan JL, Hawkins KA. The effects of apolipoprotein E on non-impaired cognitive functioning: ameta-analysis. Neurobiol Aging. 2011;32(1):63-74.
40. Burdick KE, Goldberg TE, Funke B, et al. DTNBP1 genotype influences cognitive decline in schizophrenia. Schizophr Res. 2007;89(1-3):169- 172. (Pubitemid 44881303)
41. Egan MF, Goldberg TE, Kolachana BS, et al. Effect of COMT Val108/158Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci U S A. 2001;98(12):6917-6922. (Pubitemid 32538317)
42. Egan MF, Straub RE, Goldberg TE, et al. Variation in GRM3 affects cognition, prefrontal glutamate, and risk for schizophrenia. Proc Natl Acad Sci U S A. 2004;101(34):12604-12609. (Pubitemid 39122071)
43. Goldberg TE, Straub RE, Callicott JH, et al. The G72/G30 gene complex and cognitive abnormalities in schizophrenia. Neuropsychopharmacology. 2006;31(9):2022-2032.
44. Greenwood TA, Lazzeroni LC, Murray SS, et al. Analysis of 94 candidate genes and 12 endophenotypes for schizophrenia from the Consortium on the Genetics of Schizophrenia. Am J Psychiatry. 2011;168(9):930-946.
45. Porteous DJ, Thomson P, Brandon NJ, Millar JK. The genetics and biology of DISC1: an emerging role in psychosis and cognition. Biol Psychiatry. 2006; 60(2):123-131.
46. Walters JT, Corvin A, OwenMJ, et al. Psychosis susceptibility gene ZNF804A and cognitive performance in schizophrenia. Arch Gen Psychiatry. 2010;67(7):692-700.
47. Toulopoulou T, Picchioni M, Rijsdijk F, et al. Substantial genetic overlap between neurocognition and schizophrenia: genetic modeling in twin samples. Arch Gen Psychiatry. 2007;64(12):1348-1355. (Pubitemid 350223552)
48. Fowler T, Zammit S, OwenMJ, Rasmussen F. A population-based study of shared genetic variation between premorbid IQ and psychosis among male twin pairs and sibling pairs from Sweden. Arch Gen Psychiatry. 2012;69(5):460-466.
49. de Ligt J, Willemsen MH, van Bon BW, et al. Diagnostic exome sequencing in persons with severe intellectual disability. N Engl J Med. 2012;367 (20):1921-1929.
50. Meisler MH, O'Brien JE, Sharkey LM. Sodium channel gene family: epilepsy mutations, gene interactions and modifier effects. J Physiol. 2010; 588(pt 11):1841-1848.
51. Need AC, Shashi V, Hitomi Y, et al. Clinical application of exome sequencing in undiagnosed genetic conditions. J Med Genet. 2012;49(6):353- 361.
52. Rauch A, Wieczorek D, Graf E, et al. Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: an exome sequencing study. Lancet. 2012;380(9854): 1674-1682.
53. Sanders SJ, MurthaMT, Gupta AR, et al. De novo mutations revealed by whole-exome sequencing are strongly associated with autism. Nature. 2012;485(7397):237-241.
54. FirstM, Spitzer R, Gibbon M, Williams J. Structured Clinical Interview for Axis I DSM-IV. New York, NY: Biometrics Research Dept, New State Psychiatric Institute; 1994.
55. Spitzer R, Williams J, FirstM. Structured Clinical Interview for DSM-IV, Patient Version. Arlington, VA: American Psychiatric Press; 1996.
56. Purcell S, Neale B, Todd-Brown K, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81(3):559-575. (Pubitemid 47330214)
57. Resnick SM. Matching for education in studies of schizophrenia. Arch Gen Psychiatry. 1992;49(3): 246.
58. Keefe RS, Mohs RC, Bilder RM, et al. Neurocognitive assessment in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project schizophrenia trial: development, methodology, and rationale. Schizophr Bull. 2003; 29(1):45-55. (Pubitemid 36871056)
59. Stroup TS, McEvoy JP, SwartzMS, et al. The National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project: schizophrenia trial design and protocol development. Schizophr Bull. 2003;29(1): 15-31. (Pubitemid 36871054)
60. Sullivan PF, Lin D, Tzeng JY, et al. Genomewide association for schizophrenia in the CATIE study: results of stage 1. Mol Psychiatry. 2008;13(6):570- 584. (Pubitemid 351704941)
61. Hashimoto R, Ohi K, Yasuda Y, et al. The impact of a genome-wide supported psychosis variant in the ZNF804A gene on memory function in schizophrenia. Am J Med Genet B Neuropsychiatr Genet. 2010;153B(8):1459-1464.
62. Stefansson H, Rujescu D, Cichon S, et al GROUP. Large recurrent microdeletions associated with schizophrenia. Nature. 2008;455(7210):232- 236.
63. Blokland GA, McMahon KL, Hoffman J, et al. Quantifying the heritability of task-related brain activation and performance during the N-back working memory task: a twin fMRI study. Biol Psychol. 2008;79(1):70-79.
64. Blokland GA, McMahon KL, Thompson PM, Martin NG, de Zubicaray GI, Wright MJ. Heritability of working memory brain activation. J Neurosci. 2011;31(30):10882-10890.
65. Callicott JH, Weinberger DR. Brain imaging as an approach to phenotype characterization for genetic studies of schizophrenia. Methods Mol Med. 2003;77:227-247.
66. Koten JW Jr, Wood G, Hagoort P, et al. Genetic contribution to variation in cognitive function: an FMRI study in twins. Science. 2009;323(5922): 1737-1740.
67. Colantuoni C, Lipska BK, Ye T, et al. Temporal dynamics and genetic control of transcription in the human prefrontal cortex. Nature. 2011;478(7370): 519-523.
68. Keefe RS, Bilder RM, Davis SM, et al CATIE Investigators; NeurocognitiveWorking Group. Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial. Arch Gen Psychiatry. 2007;64(6): 633-647. (Pubitemid 46878665)
69. Meisler MH, Kearney JA. Sodium channel mutations in epilepsy and other neurological disorders. J Clin Invest. 2005;115(8):2010-2017. (Pubitemid 41134136)
70. WangW, Takashima S, Segawa Y, et al. The developmental changes of Na(v)1.1 and Na(v)1.2 expression in the human hippocampus and temporal lobe. Brain Res. 2011;1389:61-70.
71. Coyle JT. The GABA-glutamate connection in schizophrenia: which is the proximate cause? Biochem Pharmacol. 2004;68(8):1507-1514. (Pubitemid 39286454)
72. Gonzalez-Burgos G, Lewis DA. NMDA receptor hypofunction, parvalbumin-positive neurons, and cortical gamma oscillations in schizophrenia. Schizophr Bull. 2012;38(5):950-957.
73. CatterallWA, Dib-Hajj S, Meisler MH, Pietrobon D. Inherited neuronal ion channelopathies: new windows on complex neurological diseases. J Neurosci. 2008;28(46):11768-11777.
74. Salinsky MC, Storzbach D, Spencer DC, Oken BS, Landry T, Dodrill CB. Effects of topiramate and gabapentin on cognitive abilities in healthy volunteers. Neurology. 2005;64(5):792-798. (Pubitemid 40316314)
75. Cirulli ET, Kasperaviciūte D, Attix DK, et al. Common genetic variation and performance on standardized cognitive tests. Eur J Hum Genet. 2010;18(7):815-820.
76. Davis OS, Butcher LM, Docherty SJ, et al. A three-stage genome-wide association study of general cognitive ability: hunting the small effects. Behav Genet. 2010;40(6):759-767.
77. Turkheimer E. Commentary: variation and causation in the environment and genome. Int J Epidemiol. 2011;40(3):598-601.